How modern infostealers target macOS systems, leverage Python‑based stealers, and abuse trusted platforms and utilities to ...

Kiteworks, helping organizations to effectively manage risk and use of private data, is partnering with Concentric AI to deliver robust capabilities for securing data in motion. According to the ...

Organizations have a wealth of unstructured data that most AI models can’t yet read. Preparing and contextualizing this data is essential for moving from AI experiments to measurable results. In ...

"All" isn't hyperbole. Nvidia is now the first company ever to surpass a $5 trillion valuation — an almost inconceivable figure — and Huang and company show no signs of slowing down. The company’s ...

Wegmans in New York City has begun collecting biometric data from anyone who enters its supermarkets, according to new signage posted at the chain's Manhattan and Brooklyn locations earlier this month ...

(WAND) - Now that Christmas is over, many towns are offering recycling for live trees. WAND News is compiling a list of Christmas tree recycling dates. The city is partnering with the Decatur Park ...

Having already made his list – and having checked it twice – Santa Claus is coming. You can track his progress on Christmas Eve. Since then, NORAD has upgraded ...

Fears about AI data centers’ water use have exploded. Experts say the reality is far more complicated than people think. When I called him to talk more about AI and water, Masley emphasized that he’s ...

WASHINGTON (AP) — President Donald Trump is planning a $12 billion farm aid package, according to a White House official — a boost to farmers who have struggled to sell their crops while getting hit ...

ORLANDO, Fla.—The leader of Gilead Sciences' Kite Pharma is sure that anito-cel, the biotech’s next-generation multiple myeloma CAR-T challenger to Carvykti, is ready for prime time—and that the ...

Kite Announces New Data for Pivotal iMMagine-1 Study at ASH 2025, Highlighting Anito-cel’s Opportunity in Relapsed or Refractory Multiple Myeloma – 96% Overall Response Rate, 74% Stringent Complete ...

Kite’s Next-Generation Bicistronic CAR T-Cell Therapies Show Encouraging Phase 1 Results in Relapsed/Refractory B-Cell Lymphoma in New Data at ASH 2025 – Initial Results from Kite-753, Optimized with ...